Hemorrhagic and Thrombotic Adverse Events Associated with Emicizumab and Extended Half-Life Factor VIII Replacement Drugs: EudraVigilance Data of 2021
JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2023）
Key words
drug monitoring,hemorrhagic disorders,hemophilia,pharmacovigilance,vascular diseases
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined